MedTrace Logo

Comparative Study Between Dexmedetomidine and Fentanyl as Adjuvants to Bupivacaine

NCT06864416 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-03-07

No results posted yet for this study

Summary

Combined femoral and sciatic nerve block provides surgical anesthesia with better cardiorespiratory stability as compared to the spinal anesthesia blockade which has side effects of hypotension, bradycardia, meningitis, post dural puncture headache, hematoma, and neurological deficit

Conditions

  • Post Operative Pain

Interventions

DRUG

dexmedetomidine as adjuvant to bupivacaine

the efficacy of addition of dexmedetomidine as adjuvants to bupivacaine in femorosciatic nerve block

DRUG

Fentanyl as adjuvant to bupivacaine

the efficacy of addition of fentanyl as adjuvants to bupivacaine in femorosciatic nerve block

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2024-10-01
Completion
2024-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06864416 on ClinicalTrials.gov